Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  11,042 نتائج ل ""DOXORUBICIN""

فلترة النتائج

Content Provider : MEDLINE
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Gemcitabine-Doxorubicin Combination Polymer-Drug Conjugate Prepared by SPAAC Click Chemistry: In Vitro Characterization.

  • Authors : Gbadegesin OD; Department of and Pharmaceutical Sciences, Howard University, Washington, DC 20059, USA.; Adesina SK

Subjects: Gemcitabine* ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/chemistry

  • Source: International journal of molecular sciences [Int J Mol Sci] 2025 Mar 20; Vol. 26 (6). Date of Electronic Publication: 2025 Mar 20.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Shikimic acid protects against doxorubicin-induced cardiotoxicity in rats.

  • Authors : Alwaili MA; Department of Biology, College of Science, Princess Nourah bint Abdulrahman University, 11671, Riyadh, Saudi Arabia.; Abu-Almakarem AS

Subjects: Doxorubicin*/Doxorubicin*/Doxorubicin*/adverse effects ; Doxorubicin*/Doxorubicin*/Doxorubicin*/toxicity ; Cardiotoxicity*/Cardiotoxicity*/Cardiotoxicity*/prevention & control

  • Source: Scientific reports [Sci Rep] 2025 Mar 08; Vol. 15 (1), pp. 8126. Date of Electronic Publication: 2025 Mar 08.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Doxorubicin PK/PD modeling in multiple myeloma: towards in silico trials.

  • Authors : Andrean D; Department of Information Engineering, University of Padova, Via Giovanni Gradenigo 6b, 35131, Padova, Italy.; Da Ros F

Subjects: Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/drug therapy ; Doxorubicin*/Doxorubicin*/Doxorubicin*/pharmacology ; Doxorubicin*/Doxorubicin*/Doxorubicin*/pharmacokinetics

  • Source: Biology direct [Biol Direct] 2025 Mar 21; Vol. 20 (1), pp. 33. Date of Electronic Publication: 2025 Mar 21.Publisher: BioMed Central Country of Publication: England NLM ID: 101258412 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6150

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Kartogenin Improves Doxorubicin-Induced Cardiotoxicity by Alleviating Oxidative Stress and Protecting Mitochondria.

  • Authors : Zhang H; Department of Pediatric Research Institute, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing 400014, China.; Key Laboratory of Children's Vital Organ Development and Diseases of Chongqing Health Commission, Chongqing 400014, China.

Subjects: Doxorubicin*/Doxorubicin*/Doxorubicin*/adverse effects ; Oxidative Stress*/Oxidative Stress*/Oxidative Stress*/drug effects ; Cardiotoxicity*/Cardiotoxicity*/Cardiotoxicity*/prevention & control

  • Source: International journal of molecular sciences [Int J Mol Sci] 2025 Mar 08; Vol. 26 (6). Date of Electronic Publication: 2025 Mar 08.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

The Impact of Hyaluronic Acid Coating on the Cationic Niosomal Surface for Doxorubicin Delivery.

  • Authors : Mazzotta E; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy.; Romeo M

Subjects: Hyaluronic Acid*/Hyaluronic Acid*/Hyaluronic Acid*/chemistry ; Hyaluronic Acid*/Hyaluronic Acid*/Hyaluronic Acid*/pharmacology ; Doxorubicin*/Doxorubicin*/Doxorubicin*/pharmacology

  • Source: Molecules (Basel, Switzerland) [Molecules] 2025 Mar 03; Vol. 30 (5). Date of Electronic Publication: 2025 Mar 03.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

PHD-2/HIF-1α axis mediates doxorubicin-induced angiogenesis in SH-SY5Y neuroblastoma microenvironment: a potential survival mechanism.

  • Authors : Abou-Shanab AM; Center of Excellence for Stem Cells and Regenerative Medicine, Zewail City of Science and Technology, Giza, 12578, Egypt.; Biomedical Sciences Program, University of Science and Technology, Zewail City of Science and Technology, Giza, 12578, Egypt.

Subjects: Doxorubicin*/Doxorubicin*/Doxorubicin*/pharmacology ; Hypoxia-Inducible Factor 1, alpha Subunit*/Hypoxia-Inducible Factor 1, alpha Subunit*/Hypoxia-Inducible Factor 1, alpha Subunit*/metabolism ; Hypoxia-Inducible Factor 1, alpha Subunit*/Hypoxia-Inducible Factor 1, alpha Subunit*/Hypoxia-Inducible Factor 1, alpha Subunit*/genetics

  • Source: Scientific reports [Sci Rep] 2025 Mar 03; Vol. 15 (1), pp. 7487. Date of Electronic Publication: 2025 Mar 03.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Enhanced Anti-Tumor Effects of Natural Killer Cell-Derived Exosomes Through Doxorubicin Delivery to Hepatocellular Carcinoma Cells: Cytotoxicity and Apoptosis Study.

  • Authors : Choi YH; Korea Institute of Medical Microrobotics, 43-26 Cheomdangwagi-ro, Buk-gu, Gwangju 61011, Republic of Korea.; Kim HY

Subjects: Doxorubicin*/Doxorubicin*/Doxorubicin*/pharmacology ; Exosomes*/Exosomes*/Exosomes*/metabolism ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy

  • Source: International journal of molecular sciences [Int J Mol Sci] 2025 Mar 01; Vol. 26 (5). Date of Electronic Publication: 2025 Mar 01.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Mitochondrial Amount Determines Doxorubicin-Induced Cardiotoxicity in Cardiomyocytes.

  • Authors : Xiong W; Department of Cardiology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.; Shanghai Institute of Precision Medicine, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200125, China.

Subjects: Doxorubicin*/Doxorubicin*/Doxorubicin*/adverse effects ; Myocytes, Cardiac*/Myocytes, Cardiac*/Myocytes, Cardiac*/metabolism ; Myocytes, Cardiac*/Myocytes, Cardiac*/Myocytes, Cardiac*/drug effects

  • Source: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2025 Mar; Vol. 12 (12), pp. e2412017. Date of Electronic Publication: 2025 Feb 07.Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Novel dual action chimera doxorubizen demonstrates superior efficacy to doxorubicin in acute leukemia.

  • Authors : Walunj D; Department of Chemical Sciences, Ariel University, PO Box 3, Ariel, 40700, Israel.; Egarmina K

Subjects: Doxorubicin*/Doxorubicin*/Doxorubicin*/pharmacology; Humans ; Animals

  • Source: Scientific reports [Sci Rep] 2025 Mar 27; Vol. 15 (1), pp. 10607. Date of Electronic Publication: 2025 Mar 27.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Simultaneous targeted delivery of doxorubicin and KRAS suppression by a hybrid molecule containing miR-143 and AS1411 aptamer.

  • Authors : Laowichuwakonnukul K; Division of Biochemistry, Department of Preclinical Science, Faculty of Medicine, Thammasat University, Pathumthani, 12120, Thailand.; Soontornworajit B

Subjects: MicroRNAs*/MicroRNAs*/MicroRNAs*/genetics ; MicroRNAs*/MicroRNAs*/MicroRNAs*/metabolism ; Doxorubicin*/Doxorubicin*/Doxorubicin*/pharmacology

  • Source: Scientific reports [Sci Rep] 2025 Mar 27; Vol. 15 (1), pp. 10590. Date of Electronic Publication: 2025 Mar 27.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  11,042 نتائج ل ""DOXORUBICIN""